The FDA has rejected Moderna’s application for a new flu vaccine utilizing mRNA technology, citing inadequate clinical trial comparisons. This decision, influenced by Health Secretary Robert Kennedy Jr.’s skepticism towards mRNA vaccines, has raised concerns among vaccine experts, including former FDA officials and Senator Patty Murray, who criticized the lack of scientific grounding. Moderna plans to appeal and has also sought approval in Europe, Canada, and Australia. The FDA’s stringent stance comes amid broader changes in vaccine policy under Kennedy’s leadership.
